Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Panacos Pharmaceuticals Inc: Premium Company Profile

Published by: Datamonitor

Published: Apr. 22, 2008 - 44 Pages


Table of Contents


Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Products & Services
Pipeline Products
AC Forecast Product Sales
Competitors and Strategic Business Relationships
Top Competitors
Key Suppliers
Key Clients
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
Appendix
Ask the analyst
Datamonitor consulting
Disclaimer
TABLE OF FIGURES
Figure 1: Panacos Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Figure 2: Panacos Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
TABLE OF TABLES
Table 1: Panacos Pharmaceuticals - Key Facts
Table 2: Panacos Pharmaceuticals - Other Locations and Subsidiaries
Table 3: Panacos Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 4: Panacos Pharmaceuticals - Key Events Impacting Share Price Performance
Table 5: Panacos Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 6: Panacos Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 7: Panacos Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
Table 8: Panacos Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
Table 9: Panacos Pharmaceuticals - In-house Pipeline Products
Table 10: Panacos Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
Table 11: Panacos Pharmaceuticals - Top Competitors
Table 12: Panacos Pharmaceuticals - Key Suppliers
Table 13: Panacos Pharmaceuticals - Key Clients
Table 14: Panacos Pharmaceuticals - Key Shareholders
Table 15: Panacos Pharmaceuticals - SWOT Analysis Summary
Table 16: Panacos Pharmaceuticals - Value Chain Analysis
Table 17: Panacos Pharmaceuticals - Scorecard
Table 18: Panacos Pharmaceuticals - Key Employees
Table 19: Panacos Pharmaceuticals - Financial and Operational Overview


Abstract

Introduction

Panacos Pharmaceuticals is a development stage biotechnology company specialized in developing antiviral products for the treatment of patients with HIV infection. The company’s lead drug candidate, bevirimat (formerly PA-457) is an HIV maturation inhibitor and also a promising new antiviral class discovered by the company’s researchers.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Panacos Pharmaceuticals’ lead product candidate, bevirimat (PA-457), is the first in a new class of oral HIV therapeutics under development called maturation inhibitors and currently in the Phase IIb stage of development. Its product pipeline also includes HIV Fusion Inhibitor for the treatment of HIV infection and PA-1050040 for HIV treatment. The company derives all of its revenues from the research grants contract with National Institutes of Health (NIH) along with research funding from the University of North Carolina related to the development of certain product candidates for the treatment of HIV infections. Panacos Pharmaceuticals’ major contributor to sales growth out to 2010 will be sales of bevirimat, which is expected to launch in the year 2010. The product is forecast to record sales of $15 million in the year of its launch.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization .

Please note: This is delivered as a Zip file.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008